Patrick Lin
Chief Business - Strategy Off at Processa Pharmaceuticals, Inc. (PCSA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$11K
Total bought / sold$28K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 2,10613,113 held (+19%) | $1.93 | $4K | -21.2% |
| Jun 16SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,83111,007 held (+20%) | $2.22 | $4K | -31.5% |
| Jun 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,5829,176 held (+21%) | $2.57 | $4K | -40.9% |
| May 19SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,3697,594 held (+22%) | $2.97 | $4K | -48.8% |
| May 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,5116,236 held (+32%) | $2.69 | $4K | -43.5% |
| Apr 17SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,3694,725 held (+41%) | $2.97 | $4K | -48.8% |
| Apr 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,6033,356 held (+91%) | $2.54 | $4K | -40.2% |
- Buy
Chief Business - Strategy Off Patrick Lin bought $4K of PCSA at $2.57 — raises the stake by 21%.
- Buy
Chief Business - Strategy Off Patrick Lin bought $4K of PCSA at $2.97 — raises the stake by 22%.
- Buy
Chief Business - Strategy Off Patrick Lin bought $4K of PCSA at $2.69 — raises the stake by 32%.
- Buy
Chief Business - Strategy Off Patrick Lin bought $4K of PCSA at $2.97 — raises the stake by 41%.
- Buy
Chief Business - Strategy Off Patrick Lin bought $4K of PCSA at $2.54 — first open-market purchase in our records; raises the stake by 91%.